Post Profile






Is Biopharma Productivity In A Sharp Decline?

There is no doubt that the number of FDA approvals for new chemical entities (NCEs) in 2016 will be lower than in the past two years. That isn’t a surprise.
read more

share

Related Posts


FDA Approves Merck's LIPTRUZET™ (ezetimibe and atorvastatin), a New Product That Can Help Powerfully

Business & Finance / Personal Finance : Savings Experiment

FDA Approves Merck's LIPTRUZET™ (ezetimibe and atorvastatin), a New Product That Can Help Powerfully Lower LDL Cholesterol LIPTRUZET Approved for Patients with Primary or Mixed Hyperlipidemia, as an Adjunct to Diet When Diet Alone I...

ADDING MULTIMEDIA: FDA Approves Merck's LIPTRUZET™ (ezetimibe and atorvastatin), a New Product That

Business & Finance / Personal Finance : Savings Experiment

ADDING MULTIMEDIA: FDA Approves Merck's LIPTRUZET™ (ezetimibe and atorvastatin), a New Product That Can Help Powerfully Lower LDL Cholesterol LIPTRUZET Approved for Patients with Primary or Mixed Hyperlipidemia, as an Adjunct to Die...

FDA Moves the Cheese on Drug Approval Numbers

Medical / Pharmaceutical : Pharma Marketing Blog

The FDA and the pharmaceutical industry are bragging about the number of "new" drugs approved in "fiscal year" 2011 (October 1, 2010 through September 30, 2011). In a report (find it on the FDA site here), FDA said it approved 35 "i...

CMA Awards 2016 Updates and Preview: Carrie Underwood and Brad Paisley to Host the Event; Joseph Kahn Working on a Star-Studded Music Video

Religion / Christianity : The Christian Post

In celebration of CMA's 50th year in the country music industry, this year's overall event is revved up twice than the past years' productions.

How Many New Drugs Did FDA Approve Last Year?

Medical / Pharmaceutical : Pharmalot

The rate at which the FDA approved new molecular entities - including NME’s filed under New Drug Applications (NDAs) and therapeutic biologics filed under Original Biologic License Applications (BLAs) - declined last year from the p...

Comments


Copyright © 2016 Regator, LLC